FDA approves Alexion's Ultomiris for another rare blood disease
October 18, 2019 at 19:52 PM EDT
The U.S. Food and Drug Administration on Friday approved Alexion Pharmaceuticals Inc's treatment for a second rare blood disorder, the company said.